🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Clinical Trials in China / NCT07727772
Starting soon Observational

Vascular Aging and Acute Kidney Injury After Cardiac Surgery

NCT07727772 · tracked via the Priya Life Science China tracker
Sponsor
Nanjing First Hospital, Nanjing Medical University
Phase
Observational
Started
2026-07-01
Last updated
2026-07-27

Condition(s) studied

Acute Kidney Injury Cardiac SurgeryPostoperative ComplicationsVascular Aging

Investigational drug(s) / intervention(s)

Multidimensional Vascular Aging Assessment

Multidimensional Vascular Aging Assessment: Perioperative assessment of vascular aging-related indicators, including noninvasive vascular assessments, hemodynamic measurements, and relevant clinical and laboratory variables. The assessment is observational and will not determine the treatment, surgical procedure, or perioperative management assigned to participants.

Study summary

This prospective observational cohort study will enroll adult patients undergoing cardiac surgery at Nanjing First Hospital, Nanjing Medical University. The study will evaluate multidimensional vascular aging markers before surgery and assess their association with postoperative acute kidney injury within 7 days after surgery. No intervention will be assigned by the study protocol, and all perioperative management will follow routine clinical practice.

Eligibility

Sex
ALL
Min age
18 Years
Max age
Healthy volunteers
No
Inclusion Criteria: * Adult patients aged 18 years or older. * Patients scheduled to undergo cardiac surgery at Nanjing First Hospital, Nanjing Medical University. * Patients who are able to provide written informed consent. * Patients who are expected to undergo perioperative vascular aging assessment and postoperative renal function monitoring according to the study protocol. Exclusion Criteria: * Patients younger than 18 years. * Patients with preoperative end-stage renal disease or maintenance dialysis. * Patients who are unable to complete the study-specified vascular aging assessment. * Patients who decline participation or withdraw informed consent.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Nanjing First Hospital, Nanjing Medical University Nanjing Jiangsu

More Nanjing First Hospital, Nanjing Medical University trials in China

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07727772 on ClinicalTrials.gov ↗ ← All trials in China